CIM
OFIX icon

Contravisory Investment Management’s Orthofix Medical OFIX Stock Holding History

Contravisory Investment Management’s Portfolio OFIX Stock Details OFIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-2,319
Closed -$123K – 299
2019
Q2 		$123K Sell
2,319
-164
-7% -$8.72K 0.05% 163
2019
Q1 		$140K Sell
2,483
-339
-12% -$19K 0.05% 158
2018
Q4 		$148K Buy
2,822
+164
+6% +$9.33K 0.06% 148
2018
Q3 		$154K Hold
2,658
– – 0.06% 154
2018
Q2 		$151K Sell
2,658
-164
-6% -$9.34K 0.06% 163
2018
Q1 		$166K Buy
+2,822
New +$158K 0.06% 160

Other funds holding OFIX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $8.43B AUM 52.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Contravisory Investment Management's OFIX Position: Q3 2019 in Review

Contravisory Investment Management sold out of Orthofix Medical (OFIX) in Q3 2019, closing a stake of 2,319 shares — an estimated $123K sold.

Contravisory Investment Management first reported a position in OFIX in Q1 2018 and held it in 6 quarters. The position peaked at $166K in Q1 2018. 158 funds tracked by Wall St. Rank hold OFIX as of Q3 2019.

  • Contravisory Investment Management reported no remaining Orthofix Medical position as of Q3 2019 after selling out during the quarter.
  • Contravisory Investment Management sold 2,319 Orthofix Medical shares in Q3 2019, an estimated $123K.
  • Contravisory Investment Management first reported a position in Orthofix Medical in Q1 2018 and held it in 6 quarters.
  • Contravisory Investment Management's Orthofix Medical position peaked at $166K in Q1 2018.
  • 158 funds tracked by Wall St. Rank held Orthofix Medical as of Q3 2019.

Based on Contravisory Investment Management's 13F filing for Q3 2019, filed 7 Oct 2019.